VolitionRx Limited
VNRX · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $52 | $51 | $135 | $165 |
| - Cash | $3 | $21 | $11 | $21 |
| + Debt | $6 | $6 | $5 | $4 |
| Enterprise Value | $54 | $36 | $129 | $149 |
| Revenue | $1 | $1 | $0 | $0 |
| % Growth | 59.1% | 153% | 240.3% | – |
| Gross Profit | $1 | $1 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$26 | -$34 | -$29 | -$26 |
| % Margin | -2,073.6% | -4,390.8% | -9,541.8% | -28,532% |
| Net Income | -$27 | -$35 | -$30 | -$27 |
| % Margin | -2,186.3% | -4,555.5% | -9,879.1% | -29,782.5% |
| EPS Diluted | -0.31 | -0.5 | -0.55 | -0.51 |
| % Growth | 38% | 9.1% | -7.8% | – |
| Operating Cash Flow | -$26 | -$18 | -$15 | -$21 |
| Capital Expenditures | -$1 | -$1 | -$2 | -$1 |
| Free Cash Flow | -$26 | -$19 | -$17 | -$22 |